Immunomodulatory Drugs Regulate HMGB1 Release from Activated Human Monocytes

Overview of attention for article published in Molecular Medicine, April 2010

Altmetric Badge

Mentioned by

twitter: 4 X users

Readers on

mendeley: 23 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 2,533 followers.

RT @GrimaldesJ: 7. CHLOROQUINE, DEXAMETASONE, GOLD SODIUM TRIOMALATE, reduce HMGB1 https://t.co/qvHXgju8A0 8. HYDROXICLOROQUINA, inhibitin…

03 Jan 2022

Reply Repost Favourite

RT @GrimaldesJ: 7. CHLOROQUINE, DEXAMETASONE, GOLD SODIUM TRIOMALATE, reduce HMGB1 https://t.co/qvHXgju8A0 8. HYDROXICLOROQUINA, inhibitin…

04 Sep 2021

Reply Repost Favourite

RT @GrimaldesJ: 7. CHLOROQUINE, DEXAMETASONE, GOLD SODIUM TRIOMALATE, reduce HMGB1 https://t.co/qvHXgju8A0 8. HYDROXICLOROQUINA, inhibitin…

07 Aug 2021

Reply Repost Favourite

7. CHLOROQUINE, DEXAMETASONE, GOLD SODIUM TRIOMALATE, reduce HMGB1 https://t.co/qvHXgju8A0 8. HYDROXICLOROQUINA, inhibiting endosomal NADPH oxidase complex, reducing HMGB1. https://t.co/IlTV1iDd6j Romulo Daniel Grimaldes Jiménez, MD Internal Medicine Jul

26 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.